United Therapeutics shows strong revenue growth, driven by Tyvaso, and maintains high margins and low debt burden. Read why I ...

A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by ...

The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

Herbert Smith Freehills’ Priyanka Madan reports on a case involving a Merck SPC which was keenly anticipated by both ...

Dogs of the Dow can be described as the 10 highest yielding stocks that are within the DJI. Read more to see the best Dog of ...

The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.

Glenmark Pharmaceuticals on Monday said it will pay USD 7 million to three entities to settle lawsuits in the US related to ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...

Glenmark Pharmaceuticals rose 2.71% to Rs 1335.50 after the company reached a settlement agreement with three plaintiffs, Humana Inc., Centene Corporation, and Kaiser Foundation Health Plan, Inc., for ...

Merck‘s performance in 2025 started rough due to weaker-than-expected results, despite surpassing Wall Street estimates with ...